CRC vs LBRT

CRC exhibits a stark divergence between analyst optimism and deteriorating fundamental data. While the Piotroski F-Score of 4/9 indicates a stable financial baseline, the company is facing a severe growth crisis with earnings plummeting 61.5% YoY. The current price of $64.74 trades slightly above the Graham Number ($62.17) and significantly above the growth-based Intrinsic Value ($29.05), suggesting the market is pricing in a recovery that is not yet visible in the data. Heavy insider selling and a bearish technical trend further offset the 'Strong Buy' analyst consensus.

LBRT exhibits a significant valuation disconnect, trading at $33.05 despite a Graham Number of $16.21 and an Intrinsic Value of $26.85. While the Piotroski F-Score of 4/9 indicates stable but mediocre financial health, the forward P/E of 93.50 suggests a looming earnings contraction or extreme overpricing. Despite a massive 1-year price surge of 175.5%, the underlying fundamentals—specifically a low operating margin of 0.37% and revenue growth lagging far behind the sector average—do not support current levels. Bearish insider activity at 52-week highs further signals a lack of confidence in further upside.